Express Diagnostics Limited

Express Diagnostics Ltd, based in Plymouth, UK, is a large, holding company with an active status, celebrating 30 years since its founding in 1994. The company employs 69 people and holds assets valued at £954,635. It operates from a real address within Plymouth Science Park and is overseen by two directors and one owner. A key feature is its e-commerce site, complemented by a 4.0 Google rating from 44 reviews, and it regularly imports optical and medical tools and devices, with seven months of import activity recorded.

The company’s primary focus is providing medical diagnostic services, specializing in Holter analysis and remote ECG interpretation. Its website highlights a comprehensive range of services, including cardiology, audiology, and respiratory testing, catering to both NHS patients and private clients. Beyond diagnostics, Express Diagnostics offers a Direct-to-Patient Ambulatory Monitoring service, delivering specialized monitors directly to patients for convenient cardiac monitoring at home. The site also showcases a wide range of devices, consumables, and staff training packages for various Holter monitors, demonstrating a commitment to providing complete solutions for healthcare professionals.

Financially, Express Diagnostics Ltd presents a mixed picture. While net assets increased by 10% to £3.1 million, current assets only increased by 12% to £950,000. Bank borrowings have disappeared completely, a positive sign, but cash reserves decreased slightly by 6% to £260,000. Turnover decreased by 24% to £290,000, and net losses deepened to -£510,000. Trade debtors increased by 24% to £630,000, suggesting potential challenges in collecting payments. The company's large size (meeting two of three criteria for turnover over £36 million, balance sheet over £18 million, and over 250 employees) suggests a significant operation, but the increased losses are a cause for concern. The financial statements were audited by Moore Kingston Smith LLP.

Overall, Express Diagnostics Ltd appears to be navigating a period of transition, balancing its established diagnostic services with potential financial pressures. The company's commitment to innovation and patient care, as evidenced by its Direct-to-Patient service and comprehensive product offerings, suggests a determination to overcome these challenges and maintain its position as a leading provider of cardiac investigation services.

Registered in England/Wales under the registration number 02958269, with a registered address at PL6 8BU, Plymouth, Devon, Plymouth Science Park, Derriford.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.